Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
  1. 4 Shares withheld for taxes Chief Operating Officer gave up 32,901 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 100,171 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 32,424 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, General Counsel gave up 34,638 shares (to pay taxes)
  5. 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 11,552 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, General Counsel gave up 40,385 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Operating Officer gave up 42,787 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 40,161 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 113,169 shares (to pay taxes)
  10. 4 Shares withheld for taxes Director gave up 2,716 shares (to pay taxes)
  11. 4 Shares withheld for taxes Director gave up 6,039 shares (to pay taxes)
  12. 4 Open-market buy Director bought 1,300,000 shares at an average $10.45 ($13,590,000)
  13. 4 Open-market sale Chief Medical Officer sold 20,000 shares at $10.50 ($210,000)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Chief Medical Officer sold 8,305 shares at $8.23 ($68,350)

Page 2 of 10 · 184 filings